FAQs - Macromolecular Crystallography
Frequently Asked Questions on the Macromolecular Crystallography beamlines (MX1 and MX2)
Showing 81 - 100 of 509 results
Frequently Asked Questions on the Macromolecular Crystallography beamlines (MX1 and MX2)
Guide to successful proposals and experiments at the Powder Diffraction beamline.
The work of the group comprises Radioactivity Measurement Standards, Radioanalytical chemistry, Environmental Radioactivity Measurement Centre, Nuclear security science and Environmental monitoring.
ANSTO to contribute to research on Next Gen Nuclear Energy Systems
ANSTO announces the recipients of the 2022 organisational awards
ANSTO has a range of capabilities and expertise to support aerospace and space research.
The release of the Oppenheimer film, the story of the director of the Manhattan Project, has prompted many people to go online and search for an explanation of the difference between fission and fusion, two fundamental scientific concepts.
$80.2 million in new funding to expand the research capabilities of the Australian Synchrotron.
The nuclear analysis team at ANSTO recently had a significant role in the re-design and optimisation of a cold neutron source facility for the reactor, its installation and the subsequent restart after a six-month shutdown.
Strategic partnership with the University of Sydney expanded to continue a long history of research collaboration.
Research and development activity explores new, boutique radioisotopes, including positron, gamma and beta/gamma emitter. The aim is to provide material for the next generation of diagnostic and therapeutic radiopharmaceuticals
ANSTO Synroc® is constructing an Australian radioactive waste treatment facility for the by-products of Molybdenum-99 (Mo-99) production.
Latest information on the scheduled supply of our nuclear medicine production.